- Home
- ADUS vs RCKT Comparison
ADUS vs RCKT Comparison
Compare ADUS & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADUS | RCKT |
|---|---|---|
| Founded | 1979 | 1999 |
| Country | United States | United States |
| Employees | 49703 | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 340.9M |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADUS | RCKT |
|---|---|---|
| Price | $110.95 | $3.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 14 |
| Target Price | ★ $138.73 | $29.12 |
| AVG Volume (30 Days) | 148.3K | ★ 1.9M |
| Earning Date | 02-23-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.76 | N/A |
| EPS | ★ 4.66 | N/A |
| Revenue | ★ $1,346,596,000.00 | N/A |
| Revenue This Year | $25.50 | N/A |
| Revenue Next Year | $7.11 | N/A |
| P/E Ratio | $23.53 | ★ N/A |
| Revenue Growth | ★ 18.77 | N/A |
| 52 Week Low | $88.96 | $2.19 |
| 52 Week High | $136.72 | $13.30 |
Technical Indicators
Market Signals| Indicator | ADUS | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 47.00 | 56.14 |
| Support Level | $105.21 | $3.36 |
| Resistance Level | $111.57 | $3.64 |
| Average True Range (ATR) | 2.55 | 0.18 |
| MACD | -0.18 | 0.01 |
| Stochastic Oscillator | 56.55 | 78.12 |
Price Performance
Historical ComparisonAbout ADUS Addus HomeCare Corporation
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, mainly to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are medical in nature to those individuals who may require assistance during an illness or after surgery.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.